.
BioEnterprise

Abeona Therapeutics Raises Additional $4.6 Million

Abeona Therapeutics, a Cleveland developer of therapies for rare genetic diseases, has raised $4.6 million in financing through warrant exercises, bringing the total amount raised to $40 million since December 2014.

Read More  >